thyroid cancer

14 May 2024

Researchers from IIS Aragón are part of the team that has just discovered a new therapy against one of the most aggressive thyroid cancers

Rebeca Sanz, researcher at IIS Aragón, is responsible for bioinformatics of the consortium and her role has been key in identifying the mechanism by which the new therapy works in aggressive anaplastic carcinomas, participated the students of the Health and Dependency Care Cycles.